Pain Relief Techniques for Rib Fractures
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests different methods to manage pain from rib fractures. Participants will join one of three groups: one using an ESP block (a type of nerve block) with ropivacaine, another using lidocaine infusions, and the last receiving standard pain treatment with various painkillers, including opioids. The researchers aim to determine which method most effectively reduces pain and opioid use in the first few days, as well as its impact on breathing and long-term pain. Individuals aged 55 and older with three or more broken ribs on one side who are hospitalized might be suitable for this trial. As a Phase 4 trial, this study involves treatments already FDA-approved and proven effective, aiming to understand how they can benefit more patients.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop your current medications. It's best to discuss this with the trial coordinators or your doctor.
What is the safety track record for these treatments?
Previous studies have shown promising safety results when using the Erector Spinae Plane (ESP) block with a catheter and ropivacaine. Research indicates that this method effectively manages pain from rib fractures, reducing pain and improving breathing without serious side effects. For instance, patients have reported better breathing and less pain without experiencing issues like low blood pressure.
Lidocaine, administered as an infusion, is also well-tolerated in controlled amounts. The FDA has approved it for various uses, suggesting it is generally safe. While side effects can occur, they are usually mild and manageable.
Overall, both treatments in the trial have demonstrated good safety records based on past research and FDA approvals, indicating they are generally safe for use in humans with minimal risk of severe side effects.12345Why are researchers enthusiastic about this study's treatments?
Researchers are excited about these treatments because they offer new ways to manage pain from rib fractures. The ESP block with catheter using ropivacaine is unique because it provides continuous pain relief directly at the site of injury, potentially reducing the need for opioids, which can have significant side effects. On the other hand, the use of lidocaine as a bolus and infusion offers a systemic pain relief alternative with a different mechanism, acting as an anesthetic by blocking nerve signals throughout the body. These treatments aim to enhance pain management while minimizing reliance on standard care options like opioids and multimodal analgesia.
What evidence suggests that this trial's treatments could be effective for rib fractures?
In this trial, participants will receive one of the following treatments for rib fracture pain: the erector spinae plane (ESP) block with ropivacaine or lidocaine infusions. Research has shown that the ESP block with ropivacaine effectively reduces pain from broken ribs, lowering pain levels by about 21% and aiding in breathing without affecting blood pressure. It also reduces the need for opioids, offering a significant advantage. Meanwhile, lidocaine infusions provide quick pain relief and are often used for their numbing effect. Both treatments in this trial aim to manage pain effectively after rib injuries.46789
Who Is on the Research Team?
Eric Schwenk, MD
Principal Investigator
Thomas Jefferson University
Are You a Good Fit for This Trial?
This trial is for adults over 55 with at least three rib fractures on one side, admitted to the hospital. They can't join if they're allergic to certain anesthetics, pregnant, have bilateral rib fractures, blood clotting issues, heart conduction problems, weigh under 40 kg or have other severe injuries or infections that could interfere.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomly assigned to one of three analgesic techniques for rib fractures: ESP block with ropivacaine, lidocaine bolus and infusion, or standard care with multimodal analgesia and opioids
Follow-up
Participants are monitored for safety and effectiveness, including opioid use and pain ratings, and the development of chronic pain and post-discharge opioid use
What Are the Treatments Tested in This Trial?
Interventions
- ESP block with catheter using ropivacaine
- Lidocaine
ESP block with catheter using ropivacaine is already approved in United States, European Union for the following indications:
- Rib fractures
- Thoracic pain management
- Rib fractures
- Thoracic pain management
Find a Clinic Near You
Who Is Running the Clinical Trial?
Thomas Jefferson University
Lead Sponsor